Rackspace Technology, Inc. CTO Sells 51,984.90 in Stock
| IVME Stock | USD 0.0001 0.00 0.00% |
About 56% of In Veritas' investor base is looking to short. The analysis of overall sentiment of trading In Veritas Medical stock suggests that many investors are alarmed at this time. The current market sentiment, together with In Veritas' historical and current headlines, can help investors time the market. In addition, many technical investors use In Veritas Medical stock news signals to limit their universe of possible portfolio assets.
IVME |
Rackspace Technology, Inc. CTO Srini Koushik sold 19,470 shares of the businesss stock in a transaction on Friday, November 29th. The shares were sold at an average price of 2.67, for a total transaction of 51,984.90. Following the completion of the transaction, the chief technology officer now owns 1,026,279 shares
Read at thelincolnianonline.com
 |
In Veritas Fundamental Analysis
We analyze In Veritas' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of In Veritas using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of In Veritas based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
In Veritas is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
In Veritas Medical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with In Veritas stock to make a market-neutral strategy. Peer analysis of In Veritas could also be used in its relative valuation, which is a method of valuing In Veritas by comparing valuation metrics with similar companies.
Peers
In Veritas Related Equities
| ZDGE | Zedge | 13.92 | ||||
| EGO | Eldorado Gold | 0.00 | ||||
| GFF | Griffon | 0.43 | ||||
| SPHR | Sphere Entertainment | 1.95 | ||||
| MTX | Minerals Technologies | 3.04 | ||||
| AVNT | Avient Corp | 8.75 |
Complementary Tools for IVME Stock analysis
When running In Veritas' price analysis, check to measure In Veritas' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy In Veritas is operating at the current time. Most of In Veritas' value examination focuses on studying past and present price action to predict the probability of In Veritas' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move In Veritas' price. Additionally, you may evaluate how the addition of In Veritas to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |